ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
89 hedge funds and large institutions have $173M invested in ChemoCentryx, Inc. in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 4 closing their positions.
450% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 4
117% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 18
98% more call options, than puts
Call options by funds: $103K | Put options by funds: $52K
26% more capital invested
Capital invested by funds: $137M → $173M (+$35.8M)
24% more funds holding
Funds holding: 72 → 89 (+17)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.72M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.01M |
| 3 |
Renaissance Technologies
New York
|
+$1.96M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.42M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$4.71M |
| 2 |
SCM
Sio Capital Management
New York
|
-$2.08M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$1.91M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$1.54M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.17M |
CCXI Hedge Fund Activity: Q4 2016 in Review
89 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2016, worth a combined $173M — up 26% from $137M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CCXI positions and 4 closed out — a net gain of 18 holders — while 39 added to existing stakes and 18 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $2.72M. The largest seller was Artal Group, cutting an estimated $4.71M.
- 89 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2016, up from 72 in Q3 2016.
- Funds reported $173M of ChemoCentryx, Inc. stock for Q4 2016, up 26% quarter-over-quarter.
- 22 funds opened new ChemoCentryx, Inc. positions in Q4 2016 and 4 closed out, a net change of +18 holders.
- The largest ChemoCentryx, Inc. buyer in Q4 2016 was AllianceBernstein, an estimated $2.72M added.
- The largest ChemoCentryx, Inc. seller in Q4 2016 was Artal Group, an estimated $4.71M sold.
Based on aggregated 13F filings for Q4 2016.